Best Fit Profiles
- homocysteine reduction, methylation support, and neurological health in aging adults
Methylation, homocysteine reduction, and neurological support
B Vitamins
The B vitamin complex (particularly B6, B9/folate, B12) supports one-carbon metabolism and homocysteine clearance. High homocysteine is an independent cardiovascular and cognitive risk factor. RCTs confirm that B vitamins meaningfully lower homocysteine. Neurological support evidence is strongest for B12 deficiency correction.
Evidence Level B
Evidence and Risk Labels
Evidence A/B/C reflects research maturity, and risk levels reflect monitoring needs. These labels support comparison, not diagnosis or treatment decisions.
See full scoring guideClinical Snapshot
- Effect Size
- Meaningful homocysteine reduction; cognitive benefit most clear in B12-deficient populations; modest neuroprotective effect in trials
- Safety
- Low Risk
Very well tolerated. Excess B6 (over 100 mg/day long-term) can cause peripheral neuropathy. Folic acid supplementation above 1 mg/day may mask B12 deficiency. Methylated forms (methylcobalamin, methylfolate) preferred in MTHFR variants.
Research Dosing
This reflects common ranges and protocols used in published studies, not personal medical advice.
- Typical Daily Dose
- B6 2-10 mg, B9 400-800 mcg (folate), B12 500-1000 mcg
- Timing
- Morning with food
- Protocol Duration in Studies
- Ongoing supplementation common in deficiency-risk populations
B12 absorption declines with age and with proton pump inhibitors; sublingual or high-dose oral forms improve uptake.